NCT04291638

Brief Summary

This study sought to evaluate an innovative post-acute continuation/transition planning treatment strategy that leveraged an in-person intensive treatment followed by online, videoconferencing-based "booster" sessions for youth with selective mutism (SM). Twenty children between the ages of 4 and 10 and their caregivers were scheduled to participate in an in-person intensive group behavioral treatment (IGBT) for SM and subsequently randomized to receive either (a) six, biweekly, hour-long, videoconferencing-delivered booster sessions or (b) no additional treatment for 12 weeks. Due to COVID-19-related physical distancing restrictions, the study team was unable to provide in-person services. Thus, the clinical trial was converted to an open-trial design focused on evaluating remote treatment options (i.e., remotely delivered caregiver training sessions and/or a remotely delivered IGBT) for these families. All families retained in the study have or will participate(d) in assessments at the following time points: Intake (i.e., 4-5 months prior to the remote IGBT); Baseline (i.e., 1 month prior to the IGBT), Post-IGBT (i.e., 2 weeks following the IGBT), and School Year Follow Up (i.e., 16 weeks following the IGBT).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 21, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 2, 2020

Completed
4 days until next milestone

Study Start

First participant enrolled

March 6, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 7, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 7, 2020

Completed
Last Updated

December 16, 2020

Status Verified

December 1, 2020

Enrollment Period

9 months

First QC Date

February 21, 2020

Last Update Submit

December 14, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Clinical Global Impressions - Improvement (CGI-I) Scale rating at Post-IGBT

    The CGI-I Scale (Guy \& Bonato, 1970) is a widely used global improvement measure; improvement is rated on a 7-point scale ranging from 1 (very much improved) to 7 (very much worse). Independent evaluators masked to family participation/progress during the intensive group behavioral treatment (IGBT) will complete the CGI-I rating. "Treatment Response" is defined as an independent evaluator rated CGI-I rating of 1 or 2 (ratings \>/= 3 represent "Treatment Nonresponse").

    Up to 3 weeks after the Intensive Group Behavioral Treatment (IGBT)

  • Clinical Global Impressions - Improvement (CGI-I) Scale rating at School Year Follow Up

    The CGI-I Scale (Guy \& Bonato, 1970) is a widely used global improvement measure; improvement is rated on a 7-point scale ranging from 1 (very much improved) to 7 (very much worse). Independent evaluators masked to family participation/progress during the intensive group behavioral treatment (IGBT) and the post-acute strategy will complete the CGI-I rating. "Treatment Response" is defined as an independent evaluator rated CGI-I rating of 1 or 2 (ratings \>/= 3 represent "Treatment Nonresponse").

    16-18 weeks after the Intensive Group Behavioral Treatment (IGBT)

Secondary Outcomes (12)

  • Change from Baseline in Anxiety Disorders Interview Schedule for Children (ADIS) Clinical Severity Ratings (CSRs) at Post-IGBT

    Up to 3 weeks after the Intensive Group Behavioral Treatment (IGBT)

  • Change from Baseline in Anxiety Disorders Interview Schedule for Children (ADIS) Clinical Severity Ratings (CSRs) at School Year Follow Up

    16-18 weeks after the Intensive Group Behavioral Treatment (IGBT)

  • Change from Post-IGBT in Anxiety Disorders Interview Schedule for Children (ADIS) Clinical Severity Ratings (CSRs) at School Year Follow Up

    16-18 weeks after the Intensive Group Behavioral Treatment (IGBT)

  • Change from Baseline in Children's Global Assessment Scale (CGAS) rating at Post-IGBT

    Up to 3 weeks after the Intensive Group Behavioral Treatment (IGBT)

  • Change from Baseline in Children's Global Assessment Scale (CGAS) rating at School Year Follow Up

    16-18 weeks after the Intensive Group Behavioral Treatment (IGBT)

  • +7 more secondary outcomes

Study Arms (2)

Remote Caregiver Training

EXPERIMENTAL

The Remote Caregiver Training arm consists of participation in a 5-hour, videoconferencing-based caregiver training program.

Behavioral: Remote Caregiver Training

Remote Caregiver Training + Intensive Treatment

EXPERIMENTAL

The Remote Caregiver Training + Intensive Treatment arm consists of participation in a 5-hour, videoconferencing-based caregiving training program, followed by participation in the videoconferencing-based intensive group behavioral treatment program.

Behavioral: Remote Caregiver TrainingBehavioral: Remote Intensive Group Behavioral Treatment (IGBT)

Interventions

The remote caregiver training is a 5-hour videoconferencing-based training program that focuses on teaching cognitive behavioral therapy skills to the caregivers of children with selective mutism in a group format across 3 sessions.

Remote Caregiver TrainingRemote Caregiver Training + Intensive Treatment

The remote IGBT is a 5-day videoconferencing-based treatment program that delivers cognitive behavioral therapy to children and their caregivers in a group format across 2-3 hours per day.

Remote Caregiver Training + Intensive Treatment

Eligibility Criteria

Age4 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Child between the ages of 4-10 years, and his or her caregiver(s)
  • Child meets DSM-5 criteria for selective mutism diagnosis
  • Child speaks English fluently

You may not qualify if:

  • Child is identified as having any psychiatric condition significantly more impairing than selective mutism that requires alternate treatment
  • The child is nonverbal with all caregivers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Florida International University

Miami, Florida, 33199, United States

Location

MeSH Terms

Conditions

Mutism

Condition Hierarchy (Ancestors)

Speech DisordersLanguage DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurodevelopmental DisordersMental Disorders

Study Officials

  • Natalie Hong, M.S.

    Florida International University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
"Independent evaluators" assigned to assess outcomes at Post-IGBT and School Year Follow-Up time points will be unfamiliar with families' progress during the IGBT, as well as masked to treatment participation (i.e., whether or not families participated in the remote IGBT).
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: All participating families attend videoconferencing-based group parent training sessions. Families are given the opportunity to opt in to participate in the videoconferencing-based intensive group behavioral treatment program (remote IGBT).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 21, 2020

First Posted

March 2, 2020

Study Start

March 6, 2020

Primary Completion

December 7, 2020

Study Completion

December 7, 2020

Last Updated

December 16, 2020

Record last verified: 2020-12

Locations